InvestorsObserver
×
News Home

Is Bristol-Myers Squibb Co (BMY) Stock a Smart Value Monday?

Monday, October 11, 2021 01:37 PM | InvestorsObserver Analysts

Mentioned in this article

Is Bristol-Myers Squibb Co (BMY) Stock a Smart Value Monday?

Bristol-Myers Squibb Co (BMY) is near the middle in its sector according to InvestorsObserver. BMY gets an overall rating of 33. That means it scores higher than 33% of stocks. Bristol-Myers Squibb Co gets a 57 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 33
BMY has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on BMY!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 33 means the stock is more attractive than 33 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bristol-Myers Squibb Co Stock Today?

Bristol-Myers Squibb Co (BMY) stock is trading at $57.20 as of 1:32 PM on Monday, Oct 11, a drop of -$0.06, or -0.1% from the previous closing price of $57.26. Volume today is below average. So far 4,877,443 shares have traded compared to average volume of 10,862,252 shares. The stock has traded between $57.01 and $57.77 so far today. Click Here to get the full Stock Report for Bristol-Myers Squibb Co stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App